Physician

Faye E Rao, MD

According to 2025 Medicare claims, Faye Rao, MD (NPI: 1508883133) practices cardiology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is RAO HEART & VASCULAR LLC (NPI: 1831864891; TIN: 871712276) and primary practice location at 36303-7013. Rao is affiliated with the CHSPSC ACO 12, LLC (ACO ID: A3722) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,157 traditional Medicare patients, billed 8,781 HCPCS/CPT codes, and received $430,270 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 4,956 prescription claims across 761 beneficiaries totaling $1,465,137 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 30 claims. Open Payments data shows 71 records totaling $1,271. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $278,818 to $1,465,137. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $38,736 to $5,345.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,652	8,682	$428,394
2016	4,280	9,625	$434,699
2017	3,809	8,483	$357,894
2018	3,613	8,680	$376,581
2019	3,515	8,809	$405,530
2020	2,822	6,625	$341,476
2021	2,416	5,997	$330,675
2022	1,072	4,362	$289,045
2023	1,927	6,350	$383,803
2024	2,157	8,781	$430,270

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	431	4,130	$278,818
2016	466	4,313	$335,287
2017	464	4,009	$376,025
2018	508	3,948	$420,492
2019	572	4,101	$496,427
2020	540	4,181	$556,567
2021	561	4,132	$648,398
2022	677	4,514	$845,867
2023	719	5,103	$1,241,244
2024	761	4,956	$1,465,137

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	175	$149,409
2016	N/R	206	$295,790
2017	N/R	111	$45,785
2018	N/R	14	$780
2019	N/R	162	$37,977
2020	N/R	66	$4,368
2021	N/R	30	$27,855
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	233	233	$283
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	959	976	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	319	374	$82
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	233	233	$44
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,964	3,003	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	645	31,032	$596,043
Camzyos	Mavacamten	27	810	$221,060
Entresto	Sacubitril/Valsartan	160	6,916	$143,910
Xarelto	Rivaroxaban	123	7,440	$136,173
Farxiga	Dapagliflozin Propanediol	49	2,850	$54,399

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$1,271	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Faye E. Rao, MD?

Tedicare shows public-source Medicare data for Faye E. Rao, MD (NPI 1508883133), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Faye E. Rao, MD have ACO affiliation data?

Faye E. Rao, MD is shown with ACO affiliation data for CHSPSC ACO 12, LLC (MSSP, ACO ID A3722) and Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Faye E. Rao, MD?

Faye E. Rao, MD is linked to RAO HEART & VASCULAR LLC (billing NPI 1831864891) in the available physician profile data.

Does Faye E. Rao, MD have Open Payments data?

Faye E. Rao, MD has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.